• A study to evaluate if hydrocortisone helps reduce symptoms of post-traumatic stress disorder in patients after exposure to a traumatic event.

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • A study to evaluate the safety and effectiveness of ADX-038 in adults with geographic atrophy caused by age-related macular degeneration.

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    Germany Italy Portugal Spain
  • Study to evaluate the effect of upadacitinib on the frequency of eye inflammation in patients with axial spondyloarthritis.

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria France Germany The Netherlands Poland Spain
  • Comparison of esketamine hydrochloride mouthwash and intravenous esketamine to reduce pain from oral mucositis in patients undergoing hematopoietic stem cell transplantation

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    The Netherlands
  • Study to evaluate the efficacy and safety of liposomal amphotericin B for patients with simple pulmonary aspergilloma

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    Latvia
  • Study of the effect of lyophilized bacterial lysates on reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD)

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Hungary
  • Comparing tenecteplase and mechanical clot removal versus mechanical clot removal alone for adults with a large ischemic stroke

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    France
  • A study to evaluate the use of tocilizumab in adults with acute ischemic stroke undergoing mechanical clot removal.

    Not yet recruiting

    2 1 1
    Denmark Norway
  • Comparing Remifentanil, Propofol, Bupivacaine, Sufentanil, and Fentanyl for patients undergoing outpatient total knee and hip replacement surgery

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Sweden
  • A study to evaluate the effect of obinutuzumab on removing specific immune cells in the tissues of patients with Sjögren’s syndrome.

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    The Netherlands

powered by